ATHE Alterity Therapeutics Limited
Healthcare$4.08-1.45%ClosedMarket Cap: $37.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.69
P/S
25.54
EV/EBITDA
-2.43
DCF Value
$-10.96
FCF Yield
-2.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
96.8%
Operating Margin
-525.6%
Net Margin
-380.7%
ROE
-30.2%
ROA
-25.6%
ROIC
-31.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | -Infinity% | $-12.8M | $-9.4M | $— | — |
| Q4 null | $3.8M | 98.3% | $-7.1M | $-5.0M | $— | — |
| FY null | $5.4M | 97.7% | $-14.6M | $-12.1M | $— | — |
| Q2 null | $1.6M | 96.0% | $-7.5M | $-7.2M | $— | — |
| Q4 null | $2.1M | 96.5% | $-13.0M | $-12.6M | $— | — |
| FY null | $4.0M | 94.7% | $-19.6M | $-19.1M | $— | — |
| Q2 null | $1.9M | 96.1% | $-4.5M | $-6.5M | $— | — |
| Q4 null | $1.5M | 96.6% | $-7.8M | $-5.8M | $— | — |
| FY null | $3.9M | 92.7% | $-14.6M | $-13.8M | $— | — |
| Q2 null | $2.4M | 97.9% | $-10.7M | $-8.0M | $— | — |
| Q4 null | $2.8M | 99.2% | $-10.5M | $-6.3M | $— | — |
| FY null | $5.1M | 92.9% | $-15.5M | $-12.8M | $— | — |